BeOne Medicines
NasdaqGS:ONC
$ 283,03
+ $6,08 (2,20%)
283,03 $
+$6,08 (2,20%)
End-of-day quote: 03/27/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

$2,53
Earnings Per Share
$48,16
Revenue Per Share
87,49%
Gross Margin %
$31,38 B
Market Cap
$0,96 B
Long-Term Debt
Earnings Per Share
$2,53
Revenue Per Share
$48,16
Gross Margin %
87,49%
Market Cap
$31,38 B
Long-Term Debt
$0,96 B

Financials

Year Year 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
EPS Earnings Per Share $2,53 $-6,12 $-8,45 $-19,43 $-15,23 $-19,13 $-15,80 $-12,15 $-2,23 $-3,84 $-6,71 $-0,08
Earnings Earnings $280,68M $-653,13M $-883,70M $-2,03B $-1,56B $-1,75B $-1,22B $-725,11M $-119,75M $-152,06M $-57,10M $-0,66M
RPS Revenue Per Share $0,00 $48,16 $35,70 $23,51 $13,57 $11,46 $3,37 $5,52 $3,32 $4,44 $0,03 $1,04 $0,00
Revenue Revenue $0,00M $5,34B $3,81B $2,46B $1,42B $1,18B $308,87M $428,21M $198,22M $238,39M $1,07M $8,82M $0,00M
OCF Operating Cash Flow $0,00M $568,49M $-140,63M $-1,16B $-1,50B $-1,30B $-1,28B $-750,27M $-547,72M $0,00M $0,00M $0,00M $0,00M
FCF Free Cash Flow $0,00M $407,37M $-633,29M $-1,72B $-1,82B $-1,56B $-1,40B $-839,88M $-618,00M $-33,62M $-113,02M $-56,75M $0,00M
OM Operating Margin 0,00% 8,37% -14,93% -49,15% -126,40% -122,31% 0,00% -224,16% 0,00% -41,30% 0,00% 0,00% -120,88%
GM % Gross Margin % 0,00% 87,49% 84,41% 84,55% 79,77% 85,98% 0,00% -133,19% -257,03% -14,94% 0,00% 0,00% -67,72%
FCFS Free Cash Flow Per Share $0,00 $7,90 $-6,36 $-16,80 $-19,06 $-17,39 $-18,10 $-15,13 $-12,42 $-1,10 $-3,64 $-5,31 $-1,22
LT Debt Long-Term Debt N/A $961,91M $166,48M $197,62M $209,15M $202,11M $183,64M $240,70M $189,67M $155,49M $17,28M $6,19M $13,52M
Sha. Stocks 110,73M 110,94M 106,72M 104,58M 104,32M 102,68M 91,6M 77,53M 59,68M 53,7M 39,6M 8,51M 8,22M
×